GOTHENBURG,Sweden,Jan. 22,2025 -- SKF's Nomination Committee proposes Mats Rahmström as a new board member in AB SKF.
Mats Rahmström was the President and CEO,as well as a member of the Board of Directors of Atlas Copco Group up until April 2024 and has held several senior positions within Atlas Copco. He has a broad international industrial background and is the Chair of the Board of Directors in Piab Group AB and a board member in Investor AB,ABB Ltd,Wärtsilä Oyj,R12 Distribution AB and Qvantum AB.
The Nomination Committee,furthermore,in addition to the proposed new election of Mats Rahmström,proposes re-election of the board members Hans Stråberg,Hock Goh,Geert Follens,Håkan Buskhe,Susanna Schneeberger,Rickard Gustafson,Beth Ferreira,Therese Friberg,Richard Nilsson and Niko Pakalén.
Hans Stråberg is proposed to be the Chair of the Board of Directors.
The Nomination Committee's additional proposals will be published in conjunction with the notice of the Annual General Meeting 2025.
The Nomination Committee for the Annual General Meeting 2025 consists of Marcus Wallenberg,FAM,Philip Ahlgren,Cevian Capital,Anders Algotsson,AFA Försäkring,and Anders Jonsson,Skandia,together with the Chair of the Board of Directors Hans Stråberg.
Aktiebolaget SKF
(publ)
For further information,please contact:
PRESS: Carl Bjernstam,Head of Media Relations
tel: 46 31-337 2517;mobile: 46 722-201 893;e-mail: carl.bjernstam@skf.com
INVESTOR RELATIONS: Sophie Arnius,Head of Investor Relations
tel: 46 31-337 8072; mobile: 46 705-908 072; e-mail: sophie.arnius@skf.com
This information was brought to you by Cision http://news.cision.com.
https://news.cision.com/skf/r/nomination-committee-s-proposal-for-board-of-directors-of-ab-skf,c4094554
The following files are available for download:
https://mb.cision.com/Main/637/4094554/3217469.pdf
20250122 Nomination Committees proposal for Board of Directors of AB SKF
https://news.cision.com/skf/i/dji-0735-fix,c3370261
DJI 0735 fix
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map